"For more than 25 years, the dedicated team of board-certified physicians, nurse practitioners, and physician assistants at North Shore Gastroenterology has been providing individualized quality care to our patients in the western and southern suburbs of Cleveland, Ohio. Working closely with your primary care physician, we specialize in diagnosing and treating gastrointestinal (GI) disorders, combining cutting-edge technology and equipment with our highly skilled expertise and a compassionate approach to meet all of our patients’ GI needs."

During the past decade, Northshore Gastroenterology Research, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northshore Gastroenterology Research, LLC" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Ellodi Pharmaceuticals, LP" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Inventiva Pharma" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Northshore Gastroenterology Research, LLC" are "Crohn's Disease" (4 trials), "Crohn Disease" (3 trials), "Colorectal Cancer" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Northshore Gastroenterology Research, LLC" in a lesser frequency.

Most popular intervention types in "Northshore Gastroenterology Research, LLC" are "Drug" (12 trials), "Biological" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Guselkumab" (3 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Northshore Gastroenterology Research, LLC" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Northshore Gastroenterology Research, LLC". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northshore Gastroenterology Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northshore Gastroenterology Research, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".